Article type
Abstract
Background
In recent years, patient-reported outcome measures (PROMs) have been widely used to evaluate the effectiveness of medical care systems because patients are the best candidates to evaluate the effects of treatments on their symptoms, physical function, and quality of life.
Objectives
The aims of this research were to construct and testify the possibility of the patient self-report adverse event system .
Methods
First of all, we analysed the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE® TRADITIONAL CHINESE version). Then, we organized the adverse events into 15 categories 78 symptoms and the last was the other sympyom that they want to report. The severity, frequency and degree of interference will be displayed after the patient has checked the symptoms to reduce information overload. And testfy and adjusted by 50 patients.
Results
This study started after passed the accepting cases on January 29, 2023 after passing the institutional review board of Taipei veterans general hospital. And, a total of 164 patients and 497 person times of information have been reported by gynecological cancer patients undergoing chemotherapy. Among them, 78 people answered only 1 time, and those who answered only 1-3 times totaled 184 people, accounting for 37.02%; those who answered 4 or more times totaled 313 people, accounting for 62.98% of the total; and those who answered 1-3 times totaled 11 times, accounting for 37.02%. A total of 126 people were admitted or above, accounting for 25.35% of the total number of people. The results showed that the number of symptom occurrences reached 21.31±14.13 times, and the number of symptoms in the first 5 years was 21.31±14.13 times. Symptoms and their incidence rates include fatigue (77.11%), numbness or tingling in hands or feet (74.10%), hair loss (65.66%), dry mouth (59.04%) and insomnia (59.04%), with a severity of 1.48± 0.76, the frequency of symptoms is 1.99±0.86, and the degree of disturbance is 1.38±0.97, indicating mild to moderate distress.
Conclusions
This study found that patients could complete self-reports of chemotherapy-related discomfort symptoms well. It is suggested reporting adverse events by patients themselves.
In recent years, patient-reported outcome measures (PROMs) have been widely used to evaluate the effectiveness of medical care systems because patients are the best candidates to evaluate the effects of treatments on their symptoms, physical function, and quality of life.
Objectives
The aims of this research were to construct and testify the possibility of the patient self-report adverse event system .
Methods
First of all, we analysed the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE® TRADITIONAL CHINESE version). Then, we organized the adverse events into 15 categories 78 symptoms and the last was the other sympyom that they want to report. The severity, frequency and degree of interference will be displayed after the patient has checked the symptoms to reduce information overload. And testfy and adjusted by 50 patients.
Results
This study started after passed the accepting cases on January 29, 2023 after passing the institutional review board of Taipei veterans general hospital. And, a total of 164 patients and 497 person times of information have been reported by gynecological cancer patients undergoing chemotherapy. Among them, 78 people answered only 1 time, and those who answered only 1-3 times totaled 184 people, accounting for 37.02%; those who answered 4 or more times totaled 313 people, accounting for 62.98% of the total; and those who answered 1-3 times totaled 11 times, accounting for 37.02%. A total of 126 people were admitted or above, accounting for 25.35% of the total number of people. The results showed that the number of symptom occurrences reached 21.31±14.13 times, and the number of symptoms in the first 5 years was 21.31±14.13 times. Symptoms and their incidence rates include fatigue (77.11%), numbness or tingling in hands or feet (74.10%), hair loss (65.66%), dry mouth (59.04%) and insomnia (59.04%), with a severity of 1.48± 0.76, the frequency of symptoms is 1.99±0.86, and the degree of disturbance is 1.38±0.97, indicating mild to moderate distress.
Conclusions
This study found that patients could complete self-reports of chemotherapy-related discomfort symptoms well. It is suggested reporting adverse events by patients themselves.